Search research articles
Contact Us
Filters
Showing results (41-50 of 46) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 46 results.
Nature Medicine
|
November 5, 2002
Induction of angiogenesis in a mouse model using engineered transcription factors
Edward J Rebar, Yan Huang, Reed Hickey, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
August 17, 2023
Anti-PD-1/Her2 Bispecific Antibody IBI315 Enhances the Treatment Effect of Her2-Positive Gastric Cancer through Gasdermin B-Cleavage Induced Pyroptosis
Wu Lin, Yingzi Zhang, Yan Yang, et al.
Cancer Immunology, Immunotherapy : CII
|
August 13, 2022
Characterization of anti-CD79b/CD3 bispecific antibody, a potential therapy for B cell malignancies
Jie Wang, Chen Li, Kaijie He, et al.
Cell Reports. Medicine
|
June 22, 2022
Optimal target saturation of ligand-blocking anti-GITR antibody IBI37G5 dictates FcγR-independent GITR agonism and antitumor activity
Huisi Liu, Weiwei Wu, Gangyu Sun, et al.
Cancer Immunology, Immunotherapy : CII
|
June 24, 2021
Combined strategies for effective cancer immunotherapy with a novel anti-CD47 monoclonal antibody
Haiqing Ni, Lei Cao, Zhihai Wu, et al.
Nature Cancer
|
August 7, 2023
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25<sup>+</sup>CD8<sup>+</sup> T cells
Weiwei Wu, Tiongsun Chia, Jia Lu, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 46) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 46 results.
Nature Medicine
|
November 5, 2002
Induction of angiogenesis in a mouse model using engineered transcription factors
Edward J Rebar, Yan Huang, Reed Hickey, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
August 17, 2023
Anti-PD-1/Her2 Bispecific Antibody IBI315 Enhances the Treatment Effect of Her2-Positive Gastric Cancer through Gasdermin B-Cleavage Induced Pyroptosis
Wu Lin, Yingzi Zhang, Yan Yang, et al.
Cancer Immunology, Immunotherapy : CII
|
August 13, 2022
Characterization of anti-CD79b/CD3 bispecific antibody, a potential therapy for B cell malignancies
Jie Wang, Chen Li, Kaijie He, et al.
Cell Reports. Medicine
|
June 22, 2022
Optimal target saturation of ligand-blocking anti-GITR antibody IBI37G5 dictates FcγR-independent GITR agonism and antitumor activity
Huisi Liu, Weiwei Wu, Gangyu Sun, et al.
Cancer Immunology, Immunotherapy : CII
|
June 24, 2021
Combined strategies for effective cancer immunotherapy with a novel anti-CD47 monoclonal antibody
Haiqing Ni, Lei Cao, Zhihai Wu, et al.
Nature Cancer
|
August 7, 2023
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25<sup>+</sup>CD8<sup>+</sup> T cells
Weiwei Wu, Tiongsun Chia, Jia Lu, et al.
Page
of 5